Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?

European Journal of Cancer Prevention

Volumn 20, Issue 2, 2011, Pages 86-95

  Bobe, Gerd ^a   Murphy, Gwen ^b   Albert, Paul S ^c   Sansbury, Leah B ^d   Young, Matthew R ^a   Lanza, Elaine ^a   Schatzkin, Arthur ^b   Colburn, Nancy H ^a   Cross, Amanda J ^b  

^a Center for Cancer Research   (United States)

^b Nutritional Epidemiology Branch   (United States)

^c Biostatistics and Bioinformatics Branch   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adenoma recurrence; flavonols; interleukins

Indexed keywords

FLAVONOL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISORHAMNETIN; KAEMPFEROL; MYRICETIN; QUERCETIN;

ADULT; AGED; ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; COLORECTAL ADENOMA; DIETARY INTAKE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR RECURRENCE;

ADENOMA; AGED; COLORECTAL NEOPLASMS; DIET; FEMALE; FLAVONOLS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKINS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 79551559161     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283429e45     Document Type: Article

References (55)

1. Block G, Hartman AM, Naughton D (1990). A reduced dietary questionnaire: development and validation. Epidemiology 1:58-64.
2. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, Ashby J, et al. (2008). Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17:1344-1353.
3. Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, et al. (2010a). Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res (Phila Pa) 3:764-775.
4. Bobe G, Murphy G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, et al. (2010b). Association between serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial. Br J Cancer 103:1453-1461.
5. Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR (2009). Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med 103:364-372.
6. Caan BJ, Lanza E, Schatzkin A, Coates AO, Brewer BK, Slattery ML, et al. (1999). Does nutritionist review of a self-administered food frequency questionnaire improve data quality? Public Health Nutr 2:565-569.
7. Cacev T, Radosevic S, Krizanac S, Kapitanovic S (2008). Influence of interleukin- 8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29:1572-1580.
8. Chun OK, Chung SJ, Song WO (2007). Estimated dietary flavonoid intake and major food sources of US adults. J Nutr 137:1244-1252.
9. Chun OK, Chung SJ, Claycombe KJ, Song WO (2008). Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in US adults. J Nutr 138:753-760.
10. Comalada M, Ballester I, Bailon E, Sierra S, Xaus J, Galvez J, et al. (2006). Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structureactivity relationship. Biochem Pharmacol 72:1010-1021.
11. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I,Woo P (1999). Polymorphic haplotypes of the interleukin-10 50 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42:1101-1118.
12. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Muller MJ (2010). Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 140:278-284.
13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 102:1369-1376.
14. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, et al. (2009). IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103-113.
15. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15:1126-1131.
16. Gupta C, Vikram A, Tripathi DN, Ramarao P, Jena GB (2010). Antioxidant and antimutagenic effect of quercetin against DEN induced hepatotoxicity in rat. Phytother Res 24:119-128.
17. Hacking D, Knight JC, Rockett K, Brown H, Frampton J, Kwiatkowski DP, et al. (2004). Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 5:274-282.
18. Hartman TJ, Yu B, Albert PS, Slattery ML, Paskett E, Kikendall JW, et al. (2005). Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas? Cancer Epidemiol Biomarkers Prev 14:2359-2365.
19. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS (2007). Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. Int J Cancer 121:2001-2004.
20. Hungness ES, Robb BW, Luo GJ, Pritts TA, Hershko DD, Hasselgren PO (2002). Proteasome inhibitors activate the transcription factors C/EBP-beta and delta in human intestinal epithelial cells. Biochem Biophys Res Commun 290:469-474.
21. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. (2002). Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123: 1793-1803.
22. Ito H, Kaneko K, Makino R, Konishi K, Kurahashi T, Yamamoto T, et al. (2007). Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 18:473-481.
23. Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ (2009). Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 106:73-82.
24. Kim WK, Bang MH, Kim ES, Kang NE, Jung KC, Cho HJ, et al. (2005). Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem 16:155-162.
25. Kokoris M, Dix K, Moynihan K, Mathis J, Erwin B, Grass P, et al. (2000). High-throughput SNP genotyping with the Masscode system. Mol Diagn 5:329-340.
26. Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, et al. (2007). Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 67: 1062-1071.
27. Kumamoto T, Fujii M, Hou DX (2009). Myricetin directly targets JAK1 to inhibit cell transformation. Cancer Lett 275:17-26.
28. Lanza E, Schatzkin A, Ballard-Barbash R, Corle D, Clifford C, Paskett E, et al. (1996). The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev 5:385-392.
29. Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R, et al. (2001). Implementation of a 4-y, high-fiber, high-fruit and vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr 74:387-401.
30. Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, et al. (2008). Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68:946-955.
31. Lin WW, Karin M (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183.
32. Luo H, Rankin GO, Liu L, Daddysman MK, Jiang BH, Chen YC (2009). Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer 61:554-563.
33. Okoko T, Oruambo IF (2009). Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells. Food Chem Toxicol 47:809-812.
34. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. (2004). Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082-1089.
35. Rees LE,Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW (2002). The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 59:560-569.
36. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T (2002). Differential regulation of interleukin-10 production by genetic and environmental factors- a twin study. Genes Immun 3:407-413.
37. Sansbury LB, Bergen AW, Wanke KL, Yu B, Caporaso NE, Chatterjee N, et al. (2006). Inflammatory cytokine gene polymorphisms, nonsteroidal antiinflammatory drug use, and risk of adenoma polyp recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 15:494-501.
38. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, et al.; Polyp Prevention Trial Study Group (2000). Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 342:1149-1155.
39. Schetter AJ, Nguyen GH, Bowman ED, Mathe EA, Yuen ST, Hawkes JE, et al. (2009). Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 15:5878-5887.
40. Schetter AJ, Heegaard NH, Harris CC (2010). Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31:37-49.
41. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E (2007). Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 6:2544-2553.
42. Slattery ML,Wolff RK, Herrick JS, Caan BJ, Potter JD (2007). IL-6 genotypes and colon and rectal cancer. Cancer Causes Control 18:1095-1105.
43. Sturlan S, Oberhuber G, Beinhauer BG, Tichy B, Kappel S,Wang J, et al. (2001). Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 22:665-671.
44. Temple SE, Lim E, Cheong KY, Almeida CA, Price P, Ardlie KG, et al. (2003). Alleles carried at positions -819 and -592 of the IL-10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 55:629-632.
45. Terry CF, Loukaci V, Green FR (2000). Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144.
46. Tsigris C, Chatzitheofylaktou A, Xiromeritis C, Nikiteas N, Yannopoulos A (2007). Genetic association studies in digestive system malignancies. Anticancer Res 27:3577-3587.
47. Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, et al. (2009). Association of common polymorphisms in IL-10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 20:1739-1751.
48. US Department of Agriculture ARS (2007). USDA database for the flavonoid content of selected foods. In Nutrient Data Laboratory website. USDA.
49. Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G (1999). The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274:32091-32098.
50. Vasku A, Vokurka J, Bienertova-Vasku J (2009). Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. Int J Colorectal Dis 24:289-294.
51. Wang L, Tu YC, Lian TW, Hung JT, Yen JH,Wu MJ (2006). Distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem 54:9798-9804.
52. Waugh DJ, Wilson C (2008). The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735-6741.
53. Yang HP,Woodson K, Taylor PR, Pietinen P, Albanes D, Virtamo J, et al. (2006). Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev 15:249-253.
54. Zhang W, Zhang F (2009). Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. Eur J Gynaecol Oncol 30:60-64.
55. Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D (2007). Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a casecontrol study in Germany. Eur J Cancer 43:1283-1289.